Functional consequences of contrasting properties of alpha 1/alpha 2 systems.
Timmermans
P B
PB
Thoolen
M J
MJ
De Jonge
A
A
Wilffert
B
B
Van Zwieten
P A
PA
D000136:Acid-Base Equilibrium; D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000818:Animals; D002121:Calcium Channel Blockers / Q000494:pharmacology; D009131:Muscle, Smooth, Vascular / Q000502:physiology*; D009543:Nifedipine / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D011311:Pressoreceptors / Q000187:drug effects; D051381:Rats; D011942:Receptors, Adrenergic, alpha / Q000502:physiology*; D014661:Vasoconstriction / Q000187:drug effects; D014664:Vasodilation / Q000187:drug effects
D000316:Adrenergic alpha-Agonists; D002121:Calcium Channel Blockers; D011942:Receptors, Adrenergic, alpha; D010643:Phenoxybenzamine; D009543:Nifedipine